We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+14.6%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$500B
AUM Growth
+$33.8B
Cap. Flow
-$25.4B
Cap. Flow %
-5.08%
Top 10 Hldgs %
30.95%
Holding
15,795
New
1,585
Increased
6,018
Reduced
6,315
Closed
1,626

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.38B
2
NVDA icon
NVIDIA
NVDA
+$732M
3
AMZN icon
Amazon
AMZN
+$606M
4
DIS icon
Walt Disney
DIS
+$559M
5
T icon
AT&T
T
+$466M

Sector Composition

Rank Sector Weight
1 Technology 3.81%
2 Healthcare 2.95%
3 Financials 2.19%
4 Consumer Discretionary 2.15%
5 Industrials 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLTH icon
13426
PUT
Duluth Holdings
DLTH
$157M
$4.3K ﹤0.01%
800
-500
-38% -$2.62K
OPRT icon
13427
CALL
Oportun Financial
OPRT
$287M
$4.3K ﹤0.01%
1,100
-4,200
-79% -$17.9K
MLYS icon
13428
CALL
Mineralys Therapeutics
MLYS
$2.38B
$4.3K ﹤0.01%
+500
New +$3.93K
TCBK icon
13429
PUT
TriCo Bancshares
TCBK
$1.87B
$4.3K ﹤0.01%
100
PRLD icon
13430
PUT
Prelude Therapeutics
PRLD
$366M
$4.27K ﹤0.01%
1,000
-200
-17% -$609
EQ icon
13431
CALL
Equillium
EQ
$145M
$4.27K ﹤0.01%
5,900
-3,000
-34% -$1.78K
SMWB icon
13432
PUT
Similarweb
SMWB
$655M
$4.26K ﹤0.01%
+800
New +$4.19K
ARC
13433
PUT
DELISTED
ARC Document Solutions, Inc.
ARC
$4.26K ﹤0.01%
1,300
-2,600
-67% -$7.63K
FISI icon
13434
PUT
Financial Institutions
FISI
$839M
$4.26K ﹤0.01%
200
-500
-71% -$8.92K
HUMA icon
13435
CALL
Humacyte
HUMA
$194M
$4.26K ﹤0.01%
1,500
SWIM icon
13436
CALL
Latham Group
SWIM
$834M
$4.21K ﹤0.01%
1,600
-8,700
-84% -$21.5K
YI
13437
CALL
111 Inc
YI
$31.4M
$4.18K ﹤0.01%
270
-140
-34% -$2.92K
INVE icon
13438
PUT
Identive
INVE
$64.1M
$4.12K ﹤0.01%
500
OTLY
13439
Oatly Group
OTLY
$449M
$4.08K ﹤0.01%
+173
New +$2.85K
FICVW
13440
DELISTED
Frontier Investment Corp Warrants
FICVW
$4.08K ﹤0.01%
75,556
+2,661
+4% +$148
IMPP icon
13441
Imperial Petroleum
IMPP
$208M
$4.07K ﹤0.01%
1,540
-160
-9% -$294
GAIA icon
13442
PUT
Gaia
GAIA
$49.1M
$4.05K ﹤0.01%
+1,500
New +$4.03K
TGAAW
13443
DELISTED
Target Global Acquisition I Corp. Warrant
TGAAW
$4.05K ﹤0.01%
57,820
+2,600
+5% +$136
TOTL icon
13444
CALL
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.03B
$4.03K ﹤0.01%
+100
New +$3.87K
TRVI icon
13445
PUT
Trevi Therapeutics
TRVI
$2.68B
$4.02K ﹤0.01%
+3,000
New +$4.54K
NAGE
13446
CALL
Niagen Bioscience
NAGE
$254M
$4K ﹤0.01%
2,800
+1,100
+65% +$1.53K
CLIR icon
13447
CALL
ClearSign Technologies
CLIR
$25.9M
$4K ﹤0.01%
360
-2,470
-87% -$25.8K
ZKIN icon
13448
ZK International Group
ZKIN
$64.2M
$3.99K ﹤0.01%
+575
New +$3.1K
DMAC icon
13449
PUT
DiaMedica Therapeutics
DMAC
$362M
$3.98K ﹤0.01%
1,400
+800
+133% +$1.98K
DFTX
13450
Definium Therapeutics
DFTX
$5.71B
$3.97K ﹤0.01%
1,085
-60,603
-98% -$182K

Similar funds

Citadel Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Citadel Advisors held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $25.4B in Q4 2023, closing 1,626 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Citadel Advisors opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.

  • Citadel Advisors's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
  • Citadel Advisors's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
  • Citadel Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
  • Citadel Advisors's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
  • Citadel Advisors opened 1,585 new positions and closed 1,626 in Q4 2023.
  • Citadel Advisors's portfolio value rose 7.2% quarter-over-quarter to $500B.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.